Janssen satellite symposium: When innovation meets patients' needs in Multiple Myeloma and Amyloidosis

4.15PM CET:
Welcome and introduction - Hareth Nahi

4.20PM CET:
Current considerations for frontline therapy in MM - Jesús San Miguel 

4.40PM CET:
Redefining the treatment paradigm in relapsed and refractory MM in the era of immunotherapy - Meletions Dimopoulos

5PM CET:
Panel discussion - all

5.10PM CET:
Patient and physician perspectives on recent advances in treatment for multiple myeloma - Yelak Biru & Francesca Gay

5.30PM CET:
Where will newer agents fit in the evolution of myeloma management? - Hermann Einsele

5.45PM CET:

Current management and future options in amyloidosis - Ashutosh Wechalekar

6.00PM CET:
Panel discussion - all

6.10PM CET:
Summary and close - Jesús San Miguel